VALARTH See Apollo Hospitals Enterprise in the appOpen in app
APOLLOHOSP · NSE · Hospital

Apollo Hospitals Enterprise Ltd

What the numbers mean, from its filings and the exchange. Data as of 13 Oct 2026.
Large Cap · AMFI list Jan-Jun 2026 · Vendor sector: Healthcare
fair low confidence No valuation within 120 days; P/E 55.2 vs peers 61.2 (4th of 11); P/B 10.7 vs peers 8.8 (9th of 10).
Statements through FY2026Prices adjusted for corporate actionsNot yet reviewed by the adversarial model

What is Apollo Hospitals Enterprise's share price today?

Apollo Hospitals Enterprise last traded at ₹7,842.50 on the NSE, as of 13 Oct 2026, 11:45 am IST, up 0.9% on the day, up 1.4% over a year. Its 52-week range is ₹6,696 to ₹9,070. The live price is in the app.

₹7,842.50 +0.9% today
+1.4% over 1 year · NSE, as of 13 Oct 2026, 11:45 am IST
60 month-end closes, 31 Oct 2021 to 30 Sep 2026, adjusted for splits and bonuses
52-week range48% of the way up
Low ₹6,696High ₹9,070

What is Apollo Hospitals Enterprise's market cap?

Apollo Hospitals Enterprise's market capitalisation is about ₹1.12 lakh crore: what it would cost to buy every share at today's price. That makes it the 85th largest large cap company we cover.

₹1.1 L Cr Large Cap85th largest large cap company
Large Cap means the 100 largest listed companies, under SEBI's rules. Shares in issue are worked out from the market cap and the price. What market cap tells you →

Key facts

From the exchange
Symbol
NSE: APOLLOHOSP
ISIN
INE437A01024
Cap bucket
Large Cap, 85th largest by market cap
Industry (NSE)
Healthcare › Healthcare Services › Hospital
Listed since
1996
Futures and options
Traded

Is Apollo Hospitals Enterprise overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 55.2 vs peers 61.2 (4th of 11); P/B 10.7 vs peers 8.8 (9th of 10).

Valuation

Latest price and trailing 12 months
P/E 55.23
vs peers 61.2 · 4th of 11
Price divided by last year's earnings per share: how many years of today's profit you pay for. Learn more →
P/B 10.72
vs peers 8.8 · 9th of 10
Price divided by book value per share: what you pay for each rupee of net assets on the balance sheet. Learn more →
Market cap ₹1.12 lakh Cr
Total market value of all shares, in ₹ crore. Learn more →
Dividend yield 0.3%
vs peers 0.2% · 4th of 7
Last year's dividends as a share of today's price. Learn more →
PEG (vendor) 1.54
vs peers 18.1 · 1st of 7
P/E divided by the vendor's earnings growth figure, which it does not disclose; a P/E adjusted for how fast profits grow. Learn more →
PEG on our 3-year EPS growth 1.66
P/E divided by the 3-year EPS growth rate from the stored accounts. Learn more →
3 models could be judged
Skipped — Fair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored

Our valuation range

🔒 Pro
Value range, implied growth at today's price, and the nine models behind it: in the app.

Is Apollo Hospitals Enterprise a quality business?

Quality score 78.1, 1st of 11 in its peer set; CLEAN on 28 of 30 flags judged.

Quality and risk

Data as of 13 Oct 2026
Business quality Not available
The kind of business, which sets the yardstick it is judged by. Learn more →
Quality score 78.1
vs peers 38.4 · 1st of 11
Returns, margins, leverage and consistency against its peers, out of 100. Learn more →
Risk level CLEAN
28 of 30 flags judged
From flags on debt, earnings quality, dilution and price swings. Learn more →

Profitability

ROE 16.0%
vs peers 9.0% · 2nd of 11
Return on equity: profit as a share of shareholders' money. Learn more →
ROCE 17.5%
vs peers 10.6% · 2nd of 11
Return on capital employed: operating profit as a share of all the capital in the business, debt and equity. Learn more →
Profit margin 7.8%
vs peers 9.9% · 7th of 11
Profit after everything, as a share of revenue. Learn more →
EPS ₹139.27
Trailing 12 months
Profit for each share over the last 12 months.

Scorecard

🔒 Pro
Health scores and red flags with their values and history: in the app.
See the scorecard →
Inside the app

Get a sneak peek of Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

Has Apollo Hospitals Enterprise made money for shareholders?

Yes: +1.4% over one year and +12.7% a year over five years.

Shareholder returns

1-year return +1.4%
Price only
What the share price did over the last 12 months. Learn more →
5-year return +12.7% a year
Price only
Yearly average price return over five years, bonuses and splits adjusted. Learn more →
Wealth destroyer No
Five-year total return — price CAGR on bonus- and split-adjusted closes plus the dividend yield — below the 7% a bank fixed deposit paid. Learn more →

Returns

3Y and 5Y are yearly averages
1W
−1.8%
1M
−10.8%
3M
−11.5%
6M
+3.4%
1Y
+1.4%
3Y
+19.2%
5Y
+12.7%

Does Apollo Hospitals Enterprise pay a dividend?

Yes. Apollo Hospitals Enterprise's dividend yield is 0.27% at the latest price; the last payout was ₹10.00 a share, ex-dividend 14 Aug 2026.

Dividends

Per share, by ex-dividend date
Dividend yield0.27%
The past 12 months' dividends as a share of today's price.
14 Aug 2026 · Final₹10.00
16 Feb 2026 · Interim₹10.00
19 Aug 2025 · Final₹10.00
14 Feb 2025 · Interim₹9.00
16 Aug 2024 · Final₹10.00
Payout ratio🔒 In the app
The share of profit paid out as dividends; a very high share leaves little to reinvest.
Dividend growth, 5 years🔒 In the app
How fast the dividend per share has grown a year.
Years without a miss🔒 In the app
How many years in a row a dividend has been paid.

Is Apollo Hospitals Enterprise growing?

Revenue 3 years 15.1% a year; profit 3 years 33.3% a year; revenue 5 years 12.2% a year.

Growth

Statements through FY2026 (Mar-26)
Revenue 3 years 15.1% a year
vs peers 18.9% · 7th of 11
Compound annual growth of revenue over three years. Learn more →
Profit 3 years 33.3% a year
vs peers 9.8% · 1st of 11
Compound annual growth of net profit over three years. Learn more →
Revenue 5 years 12.2% a year
Compound annual growth of revenue over five years. Learn more →
Profit 5 years 14.6% a year
Compound annual growth of net profit over five years. Learn more →
EPS 3 years 33.3% a year
Growth in earnings per share, so dilution counts against the company. Learn more →
EPS 5 years 66.2% a year
Growth in earnings per share over five years, so dilution counts against the company. Learn more →
P/E vs own history -24.3%
vs peers -0.7% · 1st of 8
Today's P/E against its own 5-year median; negative is cheaper than its history. Learn more →

How did Apollo Hospitals Enterprise do last quarter?

Apollo Hospitals Enterprise reported revenue of ₹7,044 Cr, up 15.8% on a year earlier and a net profit of ₹610 Cr, up 33.1% in the Jun 2026 quarter.

Latest quarter

Jun 2026
Revenue, latest quarter₹7,044 Cr
+15.8% on a year earlier
What the company took in over the quarter.
Net profit, latest quarter₹610 Cr
+33.1% on a year earlier
What was left for shareholders after every cost and tax.

How does Apollo Hospitals Enterprise compare with its peers?

Compared with 10 Hospital; 4th of 11 on P/E; 1st of 11 on quality score.

Compared with 10 Hospital

10 companies

Apollo Hospitals Enterprise against its peers

Largest 10 of 10 peers, by market cap
CompanyMarket capP/EP/BROEROCE1YQuality 🔒Rank 🔒
Apollo Hospitals Enterprise Ltd₹1.1 L Cr55.210.716.0%17.5%+1.4%
Manipal Health Enterprises Ltd₹89,321 Cr93.8—6.9%8.4%+1.8%
Max Healthcare Institute Ltd₹84,284 Cr59.010.58.3%10.3%−24.3%
Aster DM Quality Care Ltd₹59,221 Cr113.28.89.6%10.9%−3.0%
Fortis Healthcare Ltd₹57,169 Cr56.66.52.1%4.0%−30.9%
Global Health Ltd₹35,206 Cr63.46.413.2%15.9%−3.9%
Narayana Hrudayalaya Ltd₹34,582 Cr42.812.621.0%18.4%−3.8%
Krishna Institute of Medical Sciences Ltd₹29,577 Cr138.310.211.3%12.6%−1.3%
Dr Agarwals Health Care Ltd₹15,065 Cr101.96.51.9%5.0%−8.5%
Rainbow Childrens Medicare Ltd₹12,483 Cr44.57.015.7%17.3%−7.7%
Park Medi World Ltd₹10,995 Cr37.59.57.5%10.0%+72.0%
Peer median—61.28.89.0%10.6%−3.0%
Market cap in rupees crore; P/E and P/B on the latest price; 1Y is the price return over a year. A dash is a figure that does not apply or is not reported.

Full peer comparison

🔒 Pro
Every peer, every figure, the ranks and the quality and forensic scores side by side: in the app.

Who owns Apollo Hospitals Enterprise?

Apollo Hospitals Enterprise is held by promoters 28.0%, foreign institutions 43.2%, domestic institutions 22.1%.

Shareholding pattern

Latest filing, percent of shares
Promoters28.0%
The founders and controlling group.
Foreign institutions43.2%
Overseas funds investing through the FPI route.
Domestic institutions22.1%
Indian insurers, banks, pension and mutual funds together.
Mutual funds17.2%
Indian mutual fund schemes; part of domestic institutions.
Retail and others4.3%
Individual investors and everyone else.
Promoter shares pledged🔒 In the app
Promoter shares given as collateral for loans; a high share is a risk to watch.
Holding trend🔒 In the app
Whether promoters, foreign funds and mutual funds have been adding or selling over recent quarters.

What do analysts say about Apollo Hospitals Enterprise?

27 analysts cover Apollo Hospitals Enterprise, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

Analyst consensus

27 analysts
ConsensusBuy
The rating most covering analysts give the share.
Average target price🔒 In the app
The mean of the analysts' 12-month price targets.
Upside to target🔒 In the app
How far the target sits above or below today's price.
Share rating it a buy🔒 In the app
The share of covering analysts with a buy rating.

What does Apollo Hospitals Enterprise do and what is it sensitive to?

Apollo Hospitals provides healthcare services across hospitals, clinics, diagnostics and pharmacies in India, plus pharmaceutical products and digital health services. Sensitive to: foreign exchange risk on imported medical equipment.

Business-model card

FY2026 · 49 verified
4Revenue
5Channels
7Regulators
2Reg. dependencies
5Sensitivities
3Costs
4Geographies

Apollo Hospitals provides healthcare services across hospitals, clinics, diagnostics and pharmacies in India, plus pharmaceutical products and digital health services. Revenue comes from patient care delivery (inpatient and outpatient), pharmaceutical sales, and management contracts, supported by an extensive integrated network spanning urban and rural areas.

Revenue by segment

year ended March 31, 2026
Healthcare services50.1%
Retail health and diagnostics7.3%
Digital health and pharmacy distribution42.5%
Others0.0%

Revenue engine

4 verified
Healthcare services from hospitals
Outpatient and inpatient activities including physical examinations, treatments, surgeries and tests
Pharmaceutical, FMCG and private label products
Sale of goods where control transfers to customer; includes distribution through long-term supply agreements to corporates
Digital platform services
Subscription revenue and platform transaction fees from Apollo 24/7 where users book consultations, avail diagnostics and order products
1 more statement
Operation and Management (O&M) contracts and brand licenses
Revenue from O&M contracts recognised over time as services delivered; brand license fees at point licensee completes performance obligation

Customers & channels

5 verified
Hospital networks across 28 states and 4 Union territories
National geographic presence for inpatient and outpatient hospital-based care delivery
Retail healthcare formats through AHLL subsidiary
Subsidiary Apollo Health and Lifestyle Limited (AHLL) operates clinics, diagnostics, boutique birthing, short-stay surgery centers and comprehensive specialty clinics as retail touchpoints and gatekeepers to Apollo ecosystem
Digital and omnichannel platform (Apollo HealthCo)
Subsidiary Apollo HealthCo integrates virtual consultations, digital pharmacy services, and AI-powered health risk assessments to create seamless omnichannel engagement across digital and physical assets
2 more statements
Extensive pharmacy network and supply agreements
Pharmacy outlets and FMCG distribution through long-term corporate supply agreements and digital platform distribution
International information centers
Information centers in 5 countries (Africa, Middle East, Bangladesh, Bahrain and Myanmar) for medical value travel

Regulators

7 verified
Telemedicine Practice Guidelines
Governs telemedicine service delivery through digital platform consultations
Information Technology Act, 2000
Governs digital platform operations, data security and cybersecurity for electronic health records and patient information
Food Safety and Standards Act, 2006
Governs food and beverage services in hospital operations
4 more statements
Atomic Energy Act, 1962 and Radiation Protection Rules
Governs nuclear medicine, radiation therapy and imaging diagnostics using radioactive materials
Medical Termination of Pregnancy Act, 1971 and 2021 Regulations
Governs termination of pregnancy services in hospitals and clinics
Mental Healthcare Act, 2017
Governs psychiatric and mental health services delivery
Pharmacy Act, 1948
Governs pharmacy operations and pharmacist licensing

Regulatory dependencies

2 verified
Price caps on treatment costs and mandatory concessional/free treatment
Regulatory caps on fees for private hospital services and mandated concessional treatment directly reduce revenue-per-case and alter service mix. Obligation to provide free or below-cost care reduces operating margins.
Reimbursement restrictions
Insurance and government scheme reimbursement caps limit achievable pricing on insured patient populations, constraining revenue per case

Sensitivities

5 verified
Foreign exchange risk on imported medical equipment
Indian Rupee weakening against USD increases cost of imported medical equipment, consumables and technology expenditures, raising operating costs
International patient inflow and medical value travel volumes
Geopolitical developments and tensions reduce international patient inflows and medical value travel, temporarily impacting revenue from higher-margin international patients
Demand from ageing population and lifestyle diseases
Rising life expectancy increases share of elderly population, driving demand for age-related treatments and specialised care; prevalence of hypertension, diabetes and lifestyle ailments sustains chronic care demand
2 more statements
Macroeconomic growth and domestic consumption
GDP growth and rising per capita incomes drive healthcare spending; slower growth or income decline would reduce patient volumes and affordability for private care
Insurance penetration and government scheme coverage
Rising health insurance penetration and schemes like PM-JAY increase patient volumes and predictability of reimbursement, expanding addressable market

Cost inputs

3 verified
Energy (power and fuel)
Electricity for 24/7 hospital operations, backup generators and HVAC systems; fuel for ambulances and vehicles
Technology and IT infrastructure
Electronic Medical Record systems, cloud migration costs, AI platform development and digital platform operations
Debt servicing costs
Interest on borrowings (fixed and floating rate) and lease liabilities; hedging derivatives for currency and interest rate risk

Geographies

4 verified
Metropolitan urban centers (74.4%)
Core markets where 74.4% of wages (largest concentration) and majority of hospitals, diagnostics and clinics operate; highest patient volumes and case complexity
Urban areas across 24-28 Indian states (11.2%)
Secondary and Tier-2 urban markets with expanding hospital capacity and retail diagnostics; 11.16% of wage cost in FY26
Semi-urban towns (9.8%)
Emerging markets with clinic and diagnostics presence to extend reach beyond major cities; growing middle-class population
1 more statement
International markets
Medical value travel through information centers in 5 countries (Africa, Middle East, Bangladesh, Bahrain, Myanmar); represents 0.50-0.61% of turnover
Each statement is checked word for word against the FY2026 annual report; the passages are in the app.

What changed recently?

Q1 FY2027 results filed (12 Aug 2026).

Change log

6 entries · newest first
  1. Results filedQ1 FY2027 results filed.
  2. Results filedQ4 FY2026 results filed.
  3. Results filedQ3 FY2026 results filed.
  4. Results filedQ2 FY2026 results filed.
  5. Results filedQ1 FY2026 results filed.
  6. Results filedQ4 FY2025 results filed.
Get alerts →Sign in to be told when any of these change.

What this page does not tell you

What could not be judged, and why. Never empty.
  • Models not runFair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored.
  • FlagsCLEAN on 28 of 30 flags judged; no red flag; 2 could not be judged.
  • Data gapsBusiness quality: not available yet.
Not applicable to this company · 1
  • Altman ZAltman Z is a manufacturing model; a service business has no inventory or plant turnover for it to read.

What this page rests on

✓10 years of annual statements, through FY2026 (Mar-26)✓10 quarters of results✓285 months of month-end prices, adjusted for bonuses and splits○no valuation of ours yet✓business-model card FY2026 · 49 verified

Questions people ask

What is Apollo Hospitals Enterprise's share price today?

Apollo Hospitals Enterprise last traded at ₹7,842.50 on the NSE, as of 13 Oct 2026, 11:45 am IST, up 0.9% on the day, up 1.4% over a year. Its 52-week range is ₹6,696 to ₹9,070. The live price is in the app.

What is Apollo Hospitals Enterprise's market cap?

Apollo Hospitals Enterprise's market capitalisation is about ₹1.12 lakh crore: what it would cost to buy every share at today's price. That makes it the 85th largest large cap company we cover.

Is Apollo Hospitals Enterprise Ltd a large cap, mid cap or small cap?

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is a large cap company in AMFI's classification for Jan-Jun 2026. SEBI's buckets go by rank on six-month average market capitalisation: the top 100 are large caps, 101 to 250 mid caps, the rest small caps.

What is Apollo Hospitals Enterprise Ltd's P/E ratio?

55.23, vs peers 61.2 · 4th of 11. Price divided by last year's earnings per share: how many years of today's profit you pay for.

Is Apollo Hospitals Enterprise Ltd overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 55.2 vs peers 61.2 (4th of 11); P/B 10.7 vs peers 8.8 (9th of 10).

How does Apollo Hospitals Enterprise Ltd make money?

Apollo Hospitals provides healthcare services across hospitals, clinics, diagnostics and pharmacies in India, plus pharmaceutical products and digital health services. Revenue comes from patient care delivery (inpatient and outpatient), pharmaceutical sales, and management contracts, supported by an extensive integrated network spanning urban and rural areas.

Who are Apollo Hospitals Enterprise Ltd's peers?

Compared with 10 Hospital: Manipal Health Enterprises Ltd, Max Healthcare Institute Ltd, Aster DM Quality Care Ltd, Fortis Healthcare Ltd, Global Health Ltd and 5 more. The app shows how they compare on every figure.

Is this investment advice?

No. Valarth is a research and learning tool and is not a SEBI-registered investment adviser or research analyst. The figures come from the company's filings and the exchanges; what to do with them is your call.

How did Apollo Hospitals Enterprise do last quarter?

Apollo Hospitals Enterprise reported revenue of ₹7,044 Cr, up 15.8% on a year earlier and a net profit of ₹610 Cr, up 33.1% in the Jun 2026 quarter.

Who owns Apollo Hospitals Enterprise?

Apollo Hospitals Enterprise is held by promoters 28.0%, foreign institutions 43.2%, domestic institutions 22.1%.

Does Apollo Hospitals Enterprise pay a dividend?

Yes. Apollo Hospitals Enterprise's dividend yield is 0.27% at the latest price; the last payout was ₹10.00 a share, ex-dividend 14 Aug 2026.

What do analysts say about Apollo Hospitals Enterprise?

27 analysts cover Apollo Hospitals Enterprise, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

More large cap companies

Billionbrains Garage Ventures LtdGROWW · ₹1.2 L CrBajaj Holdings & Investment LtdBAJAJHLDNG · ₹1.2 L CrLTM LtdLTM · ₹1.2 L CrBritannia Industries LtdBRITANNIA · ₹1.2 L CrPower Finance Corporation LtdPFC · ₹1.1 L CrTata Power Company LtdTATAPOWER · ₹1.1 L CrGAIL (India) LtdGAIL · ₹1.1 L CrIndian BankINDIANB · ₹1.1 L Cr
All companies, by market cap →

Everything on Apollo Hospitals Enterprise, and 6,621 other companies, with 212 filters and the full peer tables

See Apollo Hospitals Enterprise in the app →See pricing